In COVID-19, we examined TGF-β1 serum concentrations in one point at hospital admission in patients with MASLD and reported that admission TGF-β1 levels were significantly higher in MASLD patients and correlated with disease severity, severe ARDS, time to recovery and mortality [20], as reported here in patients with sepsis. Here, TGFB1 is linked to COVID-19.